Maternal Depression and Epstein-Barr Virus Reactivation in Early Pregnancy
Authors:
- Sina HaeriSHSina Haeri
- Nell JohnsonNJNell Johnson
- Arthur M. BakerABArthur M. Baker
- Alison M. StuebeASAlison M. Stuebe
- Christena RainesCRChristena Raines
- David A. BarrowDBDavid A. Barrow
- Kim A. BoggessKBKim A. Boggess
- 1 April 2011
- journal article
- research article
- Published by Wolters Kluwer Health in Obstetrics & Gynecology
- Vol. 117 (4) , 862-866
Abstract
Recent evidence suggests a link between Epstein-Barr virus reactivation and chronic stress due to decreased cellular immune responses. Maternal depression complicates 10% to 20% of pregnancies and is accompanied by stress. We sought to estimate the association of Epstein-Barr virus reactivation with depression in pregnancy. In this cohort study, prevalence of Epstein-Barr virus reactivation was compared between 100 pregnant women with depression before pregnancy and a computer-generated referent group of 100 healthy women not known to be depressed. We included only those women with documented Diagnostic and Statistical Manual of Mental Disorders depression diagnoses in the current pregnancy. Serum samples were analyzed for presence of Epstein-Barr virus viral capsid antigen, nuclear antigen, and early antigen antibodies. Epstein-Barr virus reactivation was defined by presence of viral capsid antigen or nuclear antigen immunoglobulin (Ig) G, along with early antigen IgG, viral capsid antigen IgM, or both early antigen IgG and viral capsid antigen IgM. Maternal demographics were similar between the groups except for older age (34.1 compared with 32.7 years, P=.05), and lower body mass index (27.3 compared with 28.9, P=.03) among the depressed individuals. Ninety-five percent of the women were seropositive for Epstein-Barr virus. Women with depression were more likely to have Epstein-Barr virus reactivation (48% compared with 30%, P=.01) when compared with referent participants. Epstein-Barr virus reactivation remained associated with maternal depression (adjusted odds ratio 1.97, 95% confidence interval 1.10-3.77, P=.03) after controlling for potential confounders. Women with depression have higher prevalence of Epstein-Barr virus reactivation, possibly due to increased stress. II.Keywords
This publication has 23 references indexed in Scilit:
- The relationship between self-report and biomarkers of stress in low-income reproductive-age womenAmerican Journal of Obstetrics and Gynecology, 2010
- Risk factors for depressive symptoms during pregnancy: a systematic reviewAmerican Journal of Obstetrics and Gynecology, 2010
- Single-Assay Combination of Epstein-Barr Virus (EBV) EBNA1- and Viral Capsid Antigen-p18-Derived Synthetic Peptides for Measuring Anti-EBV Immunoglobulin G (IgG) and IgA Antibody Levels in Sera from Nasopharyngeal Carcinoma Patients: Options for Field ScreeningJournal of Clinical Microbiology, 2006
- Epstein–Barr virus shedding by astronauts during space flightBrain, Behavior, and Immunity, 2005
- Psychological Stress and the Human Immune System: A Meta-Analytic Study of 30 Years of Inquiry.Psychological Bulletin, 2004
- The Interrelationship of Maternal Stress, Endocrine Factors and Inflammation On Gestational LengthObstetrical & Gynecological Survey, 2003
- Maternal psychological stress and distress as predictors of low birth weight, prematurity and intrauterine growth retardationEuropean Journal of Clinical Nutrition, 2003
- Is preeclampsia an infectious disease?Acta Obstetricia et Gynecologica Scandinavica, 2001
- Depressive symptomatology during pregnancy: Evidence for an association with decreased fetal growth in pregnancies of lower social class women.Health Psychology, 2000
- Reactivation of Epstein-Barr virus in pregnant women: Social factors, and immune competence as determinants of lymphoproliferative diseases—A hypothesisMedical Hypotheses, 1982